Adherium (ASX:ADRDA) - Stock Price, News & Analysis

ADRDA Stock Overview

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

About the company

ADRDA fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	5/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 96.2% below our estimate of its fair value

Earnings are forecast to grow 97.73% per year

Earnings have grown 0.1% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (A$10M)

Shares are highly illiquid

Has less than 1 year of cash runway

Does not have meaningful revenue (A$3M)

Adherium Limited Competitors

Visionflex Group

ASX:VFX

AU$9.9m

HITIQ

ASX:HIQ

AU$9.1m

Global Health

ASX:GLH

AU$6.7m

Doctor Care Anywhere Group

ASX:DOC

AU$22.7m

Price History & Performance

Summary of all time highs, changes and price drops for Adherium
Historical stock prices
Current Share Price	AU$0.031
52 Week High	AU$0.033
52 Week Low	AU$0.025
Beta	2.4
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	24.00%

Recent updates

Shareholder Returns

	ADRDA	AU Healthcare Services	AU Market
7D	14.8%	4.8%	-0.06%
1Y	n/a	65.3%	4.3%

Return vs Industry: Insufficient data to determine how ADRDA performed against the Australian Healthcare Services industry.

Return vs Market: Insufficient data to determine how ADRDA performed against the Australian Market.

Price Volatility

Is ADRDA's price volatile compared to industry and market?
ADRDA volatility
ADRDA Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	8.0%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	17.7%
10% least volatile stocks in AU Market	3.5%

Stable Share Price: ADRDA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ADRDA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	Rick Legleiter	www.adherium.com

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution.

Adherium Limited Fundamentals Summary

How do Adherium's earnings and revenue compare to its market cap?
ADRDA fundamental statistics
Market cap	AU$10.34m
Earnings (TTM)	-AU$9.86m
Revenue (TTM)	AU$3.20m

3.2x

P/S Ratio

-1.0x

P/E Ratio

Is ADRDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADRDA income statement (TTM)
Revenue	AU$3.20m
Cost of Revenue	AU$670.00k
Gross Profit	AU$2.53m
Other Expenses	AU$12.38m
Earnings	-AU$9.86m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.03
Gross Margin	79.03%
Net Profit Margin	-308.54%
Debt/Equity Ratio	0%

How did ADRDA perform over the long term?

See historical performance and comparison

Adherium ASX:ADRDA Stock Report